Why the study?
There is a paucity of data on the cardiac manifestations of the novel coronavirus SARS-CoV-2.
COVID-19 can induce viral myocarditis mimicking Takotsubo cardiomyopathy, highlighting the need for early cardiac biomarkers and noninvasive imaging.
Answers are grounded in this paper and cite their sources.
May prompt early cardiac biomarkers and imaging in severe COVID-19; single case leaves open prevalence and management.
Currently, there is a paucity of data on the cardiac manifestations of the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present a patient with coronavirus disease 2019 (COVID-19) pneumonia complicated by hypotension and cytokine storm, followed by viral myocarditis mimicking features of Takotsubo cardiomyopathy. Rapid improvement of cardiac function after treatment highlights the importance of obtaining early cardiac biomarkers and noninvasive imaging in this patient population.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: